Amarin Corp Plcuk (AMRN) Share-based Compensation Growth (5y) (2015 - 2026)

Amarin Corp Plcuk (AMRN) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -30.06%
Dec 31, 2025 -32.48%
Sep 30, 2025 -29.93%
Jun 30, 2025 -13.02%
Mar 31, 2025 -16.39%
Dec 31, 2024 -16.11%
Sep 30, 2024 -10.02%
Jun 30, 2024 -11.06%
Mar 31, 2024 -5.39%
Dec 31, 2023 -0.54%
Sep 30, 2023 -11.51%
Jun 30, 2023 -12.70%
Mar 31, 2023 8.11%
Dec 31, 2022 13.64%
Sep 30, 2022 6.89%
Jun 30, 2022 18.99%
Mar 31, 2022 12.65%
Dec 31, 2021 25.56%
Sep 30, 2021 25.03%
Jun 30, 2021 -5.93%